MedTrace Logo

Melatonin as Adjuvant Treatment for ADHD in Adults

NCT03062839 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2018-08-15

No results posted yet for this study

Summary

This study aims to evaluate the effect of melatonin supplementation as adjuvant treatment in ADHD in adults.

Conditions

  • Attention Deficit Hyperactivity Disorder

Interventions

DRUG

Melatonin 5 mg

Melatonin 5 mg taken 30 minutes before bed time

Sponsors & Collaborators

  • Fundação de Amparo à Pesquisa do Estado de São Paulo

    collaborator OTHER_GOV

  • University of Sao Paulo

    collaborator OTHER

  • Hospital Israelita Albert Einstein

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-01
Primary Completion
2019-02-28
Completion
2019-06-30

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03062839 on ClinicalTrials.gov